top of page
Reflections on Psychiatry & Psychology


Unlocking the Brain: How the Lateral Habenula Influences Depression and Ketamine Therapy
The lateral habenula (LHb) stands out as a critical structure in understanding depression. This blog explores the LHb's role in the intricate landscape of neuroscience, its connection to depressive symptoms, and how ketamine therapy offers new hope by affecting this brain structure. The Lateral Habenula: A Critical Brain Structure The lateral habenula (LHb) is a small, symmetrical, paired nucleus located deep within the brain, nestled between the two thalamic bodies. It is in
Alexander Papp, MD
Apr 28, 20242 min read


Ketamine and the Future of Mental Health: Insights from the 2024 Oxford International Conference
The 2024 Oxford Ketamine Conference gathered global experts to discuss ketamine’s science and clinical use in mental health. Key themes included its rapid antidepressant effects, mechanisms of action, and improving treatment approaches, highlighting interdisciplinary collaboration and future research.
A. Papp MD & Julie Myers, PsyD, MSCP
Mar 31, 20242 min read


How Stress and Bipolar Disorder Interact: Causes, Course, and Treatment
Stress and bipolar disorder (BD) interact bidirectionally. Stress, particularly in early life, appears to have lasting effects and marks for early onset of BD, although the exact mechanism is poorly understood. The relationship of stress to the onset of the disorder and its course has implications for treatment and management — and perhaps even prevention.
Julie Myers, PsyD, MSCP
Feb 24, 202419 min read


The Risks of At-Home Ketamine: A Cautionary Perspective
Introduction Ketamine, an NMDA receptor antagonist, has shown promise in the treatment of various psychiatric disorders, including depression and PTSD. Its rapid-acting therapeutic effects have made it an appealing option in clinical settings under strict supervision. However, the trend towards take-home ketamine, facilitated through prescriptions for nasal sprays and oral lozenges, raises significant safety and efficacy concerns. This blog entry explores some of the reasons
Julie Myers, PsyD, MSCP
Jan 28, 20243 min read


Exploring Ketamine Therapy Risks in Light of Matthew Perry's Untimely Passing
Matthew Perry, celebrated for his iconic role on "Friends," tragically passed away on October 28, 2023, after being found unresponsive at the heated end of his swimming pool. His live-in personal assistant discovered him upon returning from errands. Despite immediate efforts to revive him, Perry was pronounced dead by emergency personnel at 4:17 p.m. Mr. Perry battled several health issues including chronic obstructive pulmonary disease (COPD), diabetes, and had a history of
Alexander Papp, MD
Dec 31, 20232 min read


A New Oral Medication for Postpartum Depression
Zurzuvae, the first FDA-approved oral pill for postpartum depression, is taken for 14 days and can reduce symptoms within days. Costing about $15,900, access may be limited despite its rapid action compared with traditional antidepressants.
Alexander Papp, MD
Nov 26, 20232 min read


Call 988!
The “988 Lifeline” service was launched in July 2022, progressing from the narrow focus on suicide prevention as the “National Suicide Prevention Lifeline” to a wider attention of forms of acute distress (and also requiring a much simpler dial code). A recent study on 988 Lifeline reveals that while it has received millions of calls, texts, and online messages, it might not be living up to its full potential. The researchers found that people dealing with severe psychologic
Alexander Papp, MD
Oct 29, 20232 min read


Understanding Methylfolate: Genetic Connection and Clinical Insights
Methylfolate, the active form of folate (B9), supports serotonin and dopamine production and may help depression, especially in people with MTHFR variants or treatment-resistant cases. It can cause GI upset or insomnia and should be used cautiously, especially with SSRIs, under medical supervision.
Alexander Papp, MD
Sep 24, 20232 min read


Cannabis DUI
In areas where cannabis is legal, more young people are driving under its influence than alcohol. Misconceptions about impairment, lack of clear THC limits, and normalization of use raise road safety concerns, highlighting the need to balance legalization with prevention.
Alexander Papp, MD
Aug 27, 20232 min read


Another Independent Pharmacy Closes in San Diego
After 30+ years serving San Diego, Point Loma Shelter Island Drug and Point Loma Cabrillo Drug closed. Crime and PBM “clawbacks” strained the small, personal pharmacies. Owner Michael Saad sold to a chain after years of 12-hour days. Loyal patrons will miss the care.
Alexander Papp, MD
Jul 30, 20232 min read


Don't Throw Out the Serotonin Theory Just Yet!
The serotonin theory of depression has been around for a good 60 years and is often used as justification for the use of antidepressants, specifically selective serotonin re-uptake inhibitors (SSRIs). Understandably, a review published recently by psychiatric researcher Joanna Moncrieff, which concluded that there was no consistent evidence of an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin act
Alexander Papp, MD
Jun 25, 20232 min read


A New PAM on the Block
Zuranolone (Zurzuvae) is the first oral GABA-modulating antidepressant for postpartum depression. Taken for 14 days, it can improve symptoms within 3 days; benefits may last weeks. Common side effects include drowsiness and dizziness.
Alexander Papp, MD
May 28, 20232 min read


The "Pipeline"
There are several exciting developments in the field of antidepressants, with various drugs currently in the pipeline. still in various stages of development. Clinical trials are ongoing to evaluate their safety, effectiveness, and potential side effects.
Alexander Papp, MD
Apr 3, 20232 min read


More on Brain Zaps
A 2022 study confirmed brain zaps as real antidepressant-withdrawal symptoms. Restarting or slowly tapering meds may help. Most improve over time, but some suffer for years. Despite this, psychiatry has shown little response.
Alexander Papp, MD
Mar 26, 20234 min read


Supplements with Antianxiety Effects
Nutraceuticals—herbs and vitamins like ashwagandha, kava, chamomile, and CBD—may ease mild anxiety but aren’t a substitute for professional treatment. Consult a healthcare provider.
Alexander Papp, MD
Feb 26, 20232 min read


Cough Medicine for Depression?
Dextromethorphan (DXM), found in cough meds, acts like mild ketamine. Combined with bupropion to slow its breakdown, it works quickly for depression. This combo was FDA-approved in 2022 as Auvelity.
Alexander Papp, MD
Jan 23, 20232 min read


Heart Rate Variability Biofeedback
Biofeedback teaches control over body functions. HRV biofeedback helps sync heart rate and breathing, boosting parasympathetic response, improving stress, anxiety, and self-regulation.
Julie Myers, PsyD, MSCP
Aug 28, 20222 min read


Cocaine and its Negative Side Effects
Cocaine blocks dopamine reuptake in the brain’s reward pathway, causing short-lived euphoria and repeated dosing. It raises heart rate and blood pressure and can cause paranoia, psychosis, heart attack, stroke, and overdose. Mixing with alcohol forms toxic cocaethylene.
Julie Myers, PsyD, MSCP
Jul 31, 20222 min read


Brain, Behavior, and Drugs
Drugs disrupt brain homeostasis by hijacking the dopamine-based reward system, producing powerful reinforcement and cravings. Repeated use causes brain adaptations, impaired impulse control, and stress-driven relapse. Genetics and environment increase risk, but recovery is possible through strengthened top-down control.
Julie Myers, PsyD, MSCP
Jun 26, 202213 min read


The Diagnosis of Bipolar II Disorder
Bipolar II disorder alternates between depression and hypomania but is hard to diagnose because patients often enjoy or fail to recognize hypomania and seek help only during depression. Recollections may be distorted, so collateral history from others is often crucial for accurate diagnosis.
Julie Myers, PsyD, MSCP
May 29, 20222 min read
bottom of page